133 related articles for article (PubMed ID: 9582529)
1. Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenoma using quantitative pathological features. A case-control study.
Meijer GA; Baak JP; Talbot IC; Atkin WS; Meuwissen SG
J Pathol; 1998 Jan; 184(1):63-70. PubMed ID: 9582529
[TBL] [Abstract][Full Text] [Related]
2. A monotonous population of elongated cells (MPECs) in colorectal adenoma indicates a high risk of metachronous cancer.
Soreide K; Buter TC; Janssen EA; van Diermen B; Baak JP
Am J Surg Pathol; 2006 Sep; 30(9):1120-9. PubMed ID: 16931957
[TBL] [Abstract][Full Text] [Related]
3. Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.
Moon CM; Cheon JH; Choi EH; Kim ES; Park JJ; Han SY; Kim DH; Kim TI; Kim WH
J Clin Gastroenterol; 2010 Aug; 44(7):495-501. PubMed ID: 20351568
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence.
Nusko G; Hahn EG; Mansmann U
Scand J Gastroenterol; 2009; 44(6):736-44. PubMed ID: 19277927
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the risk for metachronous colorectal neoplasms following intestinal polypectomy: a clinical, endoscopic and pathological study.
Fornasarig M; Valentini M; Poletti M; Carbone A; Bidoli E; Sozzi M; Cannizzaro R
Hepatogastroenterology; 1998; 45(23):1565-72. PubMed ID: 9840106
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.
Atkin WS; Morson BC; Cuzick J
N Engl J Med; 1992 Mar; 326(10):658-62. PubMed ID: 1736104
[TBL] [Abstract][Full Text] [Related]
7. Right-sided shift found in metachronous colorectal adenomas.
Nusko G; Mansmann U; Wiest G; Brueckl W; Kirchner T; Hahn EG
Endoscopy; 2001 Jul; 33(7):574-9. PubMed ID: 11473327
[TBL] [Abstract][Full Text] [Related]
8. [Do metachronous colorectal adenomas show proximal shift?].
Borda Martín A; Martínez-Peñuela JM; Muñoz-Navas M; Borda Celaya F; Jiménez Pérez J; Carretero Ribón C
Gastroenterol Hepatol; 2010; 33(6):419-24. PubMed ID: 20374971
[TBL] [Abstract][Full Text] [Related]
9. [Colorectal metachronous tumors].
Cerdán J; Torres-Melero J; Diez M; Balsa T; Balibrea JL
Rev Esp Enferm Dig; 1996 Oct; 88(10):655-9. PubMed ID: 8983303
[TBL] [Abstract][Full Text] [Related]
10. Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypectomy.
Fukutomi Y; Moriwaki H; Nagase S; Tajika M; Naito T; Miwa Y; Yamada Y; Araki H; Okuno M; Nagura K; Kato T; Ninomiya M
J Cancer Res Clin Oncol; 2002 Oct; 128(10):569-74. PubMed ID: 12384801
[TBL] [Abstract][Full Text] [Related]
11. Metachronous colorectal cancer.
Park IJ; Yu CS; Kim HC; Jung YH; Han KR; Kim JC
Colorectal Dis; 2006 May; 8(4):323-7. PubMed ID: 16630238
[TBL] [Abstract][Full Text] [Related]
12. Right-side shift of metachronous colorectal adenomas after polypectomy.
Yamaji Y; Mitsushima T; Yoshida H; Watabe H; Okamoto M; Ikuma H; Wada R; Kawabe T; Omata M
Scand J Gastroenterol; 2007 Dec; 42(12):1466-72. PubMed ID: 17852868
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
Winawer SJ; Zauber AG; Fletcher RH; Stillman JS; O'Brien MJ; Levin B; Smith RA; Lieberman DA; Burt RW; Levin TR; Bond JH; Brooks D; Byers T; Hyman N; Kirk L; Thorson A; Simmang C; Johnson D; Rex DK; ;
Gastroenterology; 2006 May; 130(6):1872-85. PubMed ID: 16697750
[TBL] [Abstract][Full Text] [Related]
14. Comparison of classic and quantitative prognostic factors in colorectal cancer.
Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
[TBL] [Abstract][Full Text] [Related]
15. Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings.
van Enckevort CC; de Graaf AP; Hollema H; Sluiter WJ; Kleibeuker JH; Koornstra JJ
Neth J Med; 2014 Apr; 72(3):139-45. PubMed ID: 24846927
[TBL] [Abstract][Full Text] [Related]
16. Comparison of malignant potential between serrated adenomas and traditional adenomas.
Song SY; Kim YH; Yu MK; Kim JH; Lee JM; Son HJ; Rhee PL; Kim JJ; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2007 Nov; 22(11):1786-90. PubMed ID: 17914951
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
[TBL] [Abstract][Full Text] [Related]
18. Prognostic model for patients treated for colorectal adenomas with regard to development of recurrent adenomas and carcinoma.
Jensen P; Krogsgaard MR; Christiansen J
Eur J Surg; 1996 Mar; 162(3):229-34; discussion 235. PubMed ID: 8695739
[TBL] [Abstract][Full Text] [Related]
19. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.
Shimizu M; Fukutomi Y; Ninomiya M; Nagura K; Kato T; Araki H; Suganuma M; Fujiki H; Moriwaki H
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3020-5. PubMed ID: 18990744
[TBL] [Abstract][Full Text] [Related]
20. Is MSI-H of value in predicting the development of metachronous colorectal cancer?
Lawes DA; Pearson T; Sengupta S; Boulos PB
Eur J Cancer; 2006 Mar; 42(4):473-6. PubMed ID: 16427780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
